Charting New Roads
Awareness changes your destiny
A new blood test known as Signatera has shown incredible ability to detect cancer relapses long before traditional scans, making it a game changer for patients.
The President of the American Society for Clinical Oncology shared that new research has found that the Lynparza parp inhibitor could have a significant impact
New research finds a connection between ancestry and Alzheimer’s disease, which can help improve early detection and management.
Findings from a PARP inhibitor study presented at the Society of Gynecologic Oncology’s virtual medical conference have shown promising results.
What are BRCA1 and BRCA2 mutated genes? Who is at risk? What does prevention/counseling look like for those with the mutation?
The Tzippora Fried Alzheimer’s Center in Israel has continued to operate in full swing over the past year, despite the challenges of the coronavirus.
Researchers from the Moffitt Cancer Center have developed a deep learning model that can identify the course of treatment for certain types of lung cancer.